TY - JOUR
AU - Schüz, Joachim
AU - Espina, Carolina
AU - Villain, Patricia
AU - Herrero, Rolando
AU - Leon, Maria E
AU - Minozzi, Silvia
AU - Romieu, Isabelle
AU - Segnan, Nereo
AU - Wardle, Jane
AU - Wiseman, Martin
AU - Belardelli, Filippo
AU - Bettcher, Douglas
AU - Cavalli, Franco
AU - Galea, Gauden
AU - Lenoir, Gilbert
AU - Martin-Moreno, Jose M
AU - Nicula, Florian Alexandru
AU - Olsen, Jørgen H
AU - Patnick, Julietta
AU - Primic-Zakelj, Maja
AU - Puska, Pekka
AU - van Leeuwen, Flora E
AU - Wiestler, Otmar
AU - Zatonski, Witold
TI - European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.
JO - Cancer epidemiology
VL - 39 Suppl 1
SN - 1877-7821
CY - Amsterdam [u.a.]
PB - Elsevier
M1 - DKFZ-2017-03515
SP - S1 - S10
PY - 2015
AB - This overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or to participate in organised intervention programmes. The Code should also form a base to guide national health policies in cancer prevention. The 12 recommendations are: not smoking or using other tobacco products; avoiding second-hand smoke; being a healthy body weight; encouraging physical activity; having a healthy diet; limiting alcohol consumption, with not drinking alcohol being better for cancer prevention; avoiding too much exposure to ultraviolet radiation; avoiding cancer-causing agents at the workplace; reducing exposure to high levels of radon; encouraging breastfeeding; limiting the use of hormone replacement therapy; participating in organised vaccination programmes against hepatitis B for newborns and human papillomavirus for girls; and participating in organised screening programmes for bowel cancer, breast cancer, and cervical cancer.
LB - PUB:(DE-HGF)16
C6 - pmid:26164654
DO - DOI:10.1016/j.canep.2015.05.009
UR - https://inrepo02.dkfz.de/record/127492
ER -